Protein Kinase Inhibitors (DBCOND0040227)

Identifiers

Synonyms

Protein Kinase Inhibitor / Product containing protein kinase inhibitor (product) / Substance with protein kinase inhibitor mechanism of action (substance) / Protein kinase inhibitor (disposition)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00676299	A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.	No drug interventions	treatment	1	completed
NCT06128148	Study of Oral JYP0322 in Patients With Locally Advanced or Metastatic Cancer Targeting ROS1 Molecular Fusion.	No drug interventions	treatment	1	recruiting
NCT04862780	(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC	Osimertinib Tigozertinib	treatment	1 / 2	active_not_recruiting
NCT03091192	Savolitinib vs. Sunitinib in MET-driven PRCC.	Savolitinib Sunitinib	treatment	3	active_not_recruiting
NCT06535568	Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB	No drug interventions	treatment	Not Available	not_yet_recruiting
NCT04518852	TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC	Sorafenib	treatment	2	completed
NCT05153408	(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC	Carboplatin Osimertinib Pemetrexed	treatment	1	terminated